Systematic Evaluation of This Case

Summary of Key Clinical Features

The Critical Diagnostic Problem

• Western Ghats travel (Shivamogga — endemic for scrub typhus, malaria, and other infections)
• Prolonged fever >13 days
• Hepatosplenomegaly + non-tender
• Direct-predominant hyperbilirubinemia (cholestatic pattern)
• Caudate lobe hypertrophy on CT
• Bilateral perinephric fat stranding
• Failure to respond to ceftriaxone + doxycycline

Differential Diagnosis (Prioritized)

Tier 1 — Must Exclude Urgently

1. Malaria (especially P. vivax or P. falciparum)

• This is the single most important diagnosis to exclude and the most likely undiagnosed cause.
• Shivamogga district (Karnataka) is a high malaria-endemic zone, particularly P. vivax and P. falciparum.
• Can cause prolonged fever, massive hepatosplenomegaly, jaundice, thrombocytopenia, and perinephric involvement.
• Widal, dengue, lepto negativity makes malaria rise to the top.
• Peripheral smear and/or RDT/PCR must be done repeatedly (3 thick + thin smears at different time points if initial is negative).
• Ceftriaxone + doxycycline do NOT cover malaria — explains non-response.

Action: Repeat malarial antigen card (Pf/Pv combo), repeat peripheral smear (ideally during fever spike), send malaria PCR if available.

2. Scrub Typhus (Orientia tsutsugamushi)

• Shivamogga is highly endemic for scrub typhus. Karnataka reported significant outbreaks.
• Weil-Felix (OX-K) has very poor sensitivity (~40–50%) — a normal result does NOT exclude scrub typhus. Per Harrison's (p. 5412), IFA serology and PCR from eschar are the mainstays.
• Look for an eschar — often missed on initial exam. Check hairline, axillae, groin, behind ears, perineum, between toes.
• Caudate lobe hypertrophy can be seen in rickettsial hepatitis.
• However — he is already on doxycycline and still spiking → either the dose/duration is insufficient, or scrub typhus is not the diagnosis, OR there is doxycycline-resistant scrub typhus (reported from South/Southeast Asia).
• Action: Send scrub typhus IgM by ELISA or IFA (not Weil-Felix). If scrub typhus IgM positive with persistent fever on doxycycline → switch to azithromycin or add rifampicin.

3. Enteric Fever with Hepatitis (Salmonella typhi/paratyphi)

• Widal is notorious for false negatives early in disease and is unreliable as a standalone test.
• Enteric fever can cause hepatitis with direct-predominant bilirubin + rising transaminases.
• Action: Blood culture (×2–3, ideally before/during antibiotic escalation) — gold standard. Bone marrow culture if blood cultures negative.

Tier 2 — Important Considerations

4. Visceral Leishmaniasis (Kala-Azar)

• Karnataka has pockets of VL, though less common than Bihar/Jharkhand.
• Goa + Shivamogga travel in an immunocompromised host (new DM, possible alcohol use) raises consideration.
• Classical triad: prolonged fever + progressive splenomegaly + weight loss. Caudate lobe hypertrophy is unusual but hepatomegaly is characteristic.
• Action: rK39 rapid card test, rK39 ELISA, splenic aspirate/bone marrow aspirate for Leishman-Donovan bodies if high suspicion.

5. Hepatic Abscess / Amebic Abscess

• CT did not mention a focal lesion — but early abscess can appear as diffuse hepatomegaly.
• Alcohol history is relevant for amebic susceptibility.
• Action: Serum ameba antibody (IHA or ELISA), and if CT does not clearly show focal lesion, consider repeat CT or hepatic ultrasound with contrast.

6. Leptospirosis — Reconsider

• Card test has poor sensitivity — only ~50–60%. Weil-Felix is irrelevant here.
• Perinephric fat stranding on CT is a hallmark of leptospirosis (perirenal inflammation, interstitial nephritis).
• Direct-predominant jaundice + hepatosplenomegaly + fever also fits.
• Action: MAT (Microscopic Agglutination Test) — gold standard for lepto; send leptospira IgM by ELISA (more sensitive than card). Also send urine dark-field microscopy or urine PCR (leptospires shed in urine from Day 7–8 onward).

7. Brucellosis

• Travel, animal exposure (Goa coastal area, rural Shivamogga — cattle).
• Hepatosplenomegaly, prolonged undulating fever, normal/mildly elevated LFT.
• Action: Brucella serology (SAT/Rose Bengal + Brucella IgG/IgM ELISA), blood culture in specific media.

8. Tuberculosis — Disseminated

• DM2 is a major risk factor. Hepatosplenomegaly, fever >2 weeks, raised ALP (ALP 175 — relatively selective for hepatic TB).
• Caudate lobe involvement can be seen in granulomatous hepatitis from TB.
• Action: Sputum AFB + CBNAAT, IGRA/Quantiferon, ADA levels, bone marrow biopsy if other etiologies excluded.

Tier 3 — Do Not Miss

9. Hemophagocytic Lymphohistiocytosis (HLH) — Secondary

• Any of the above infections (especially EBV, scrub typhus, visceral leishmaniasis) can trigger HLH in an immunocompromised host (new DM).
• Hyperferritinemia is the key clue.
• Action: Serum ferritin (if >500 ng/mL, very suspicious; >10,000 near-diagnostic). Also send fibrinogen, triglycerides, LDH.

10. EBV/CMV Hepatitis

• Infectious mononucleosis-type illness with hepatosplenomegaly.
• Action: EBV VCA IgM, CMV IgM, Monospot test.

Structured Workup Plan

Urgent (Today)

Second Line (within 24–48h)

LFT Pattern Interpretation

• Budd-Chiari syndrome (hepatic vein outflow obstruction) — the caudate lobe drains separately into the IVC and hypertrophies compensatorily
• Chronic liver disease with altered hemodynamics

Action: CT with hepatic venous phase / triphasic CT or MRI abdomen with MRCP to specifically assess hepatic vein patency and rule out Budd-Chiari. This is a critical finding that could explain the cholestatic (direct-predominant) jaundice + hepatosplenomegaly + perinephric stranding (venous congestion to kidneys).

Antibiotic Strategy

Key Clinical Pearls

1. Weil-Felix has <50% sensitivity for scrub typhus — a negative result is virtually meaningless. IFA or IgM ELISA must be done.
2. The perinephric fat stranding is a critical CT clue — top two diagnoses are leptospirosis (interstitial nephritis) and Budd-Chiari/hepatic venous congestion causing perirenal edema.
3. Caudate lobe hypertrophy is pathognomonic for hepatic outflow obstruction (Budd-Chiari) until proven otherwise — triphasic CT or MRI liver with venography is mandatory.
4. Newly detected DM in this acute setting may represent either stress hyperglycemia from infection OR be a genuine predisposing immunocompromised state.
5. Shivamogga (Western Ghats) is co-endemic for scrub typhus, malaria, leptospirosis, and rickettsial diseases — co-infection is possible.
6. Day 13 with persistent fever despite broad-spectrum cover — this pattern strongly favors a non-bacterial etiology (malaria, viral, VL, HLH, Budd-Chiari) or drug-resistant/inadequate-coverage bacterial cause.

Bottom Line Priority

The single most important next step is a malaria peripheral smear and RDT right now. After that, triphasic CT/MRI liver to evaluate the caudate lobe hypertrophy for Budd-Chiari, scrub typhus IgM ELISA (not Weil-Felix), leptospira MAT/IgM ELISA, and serum ferritin to screen for HLH. These five investigations will most likely crack this case.

Updated Analysis — Malaria Ruled Out Twice

Reframed Differential — Ranked by Probability

🔴 Priority 1: Scrub Typhus with Doxycycline Resistance / Inadequate Serology Testing

Two critical questions:

1. Has scrub typhus IgM ELISA been done (not just Weil-Felix)?
2. Is the patient on oral doxycycline — because in severe/hepatitis cases, IV doxycycline achieves better bioavailability?

• Send scrub typhus IgM ELISA immediately if not done
• If positive (or even strongly suspected) → switch to azithromycin 500mg OD (3–5 days) or add rifampicin 600mg OD
• Scrub typhus IgM can be negative in the first week but is usually positive by Day 10–14

🔴 Priority 2: Budd-Chiari Syndrome (BCS)

"Doppler ultrasonography, CT, or MR are the mainstay. Typical features include thrombus, nonvisualization of hepatic veins, caudate lobe hypertrophy, caudate vein >3mm, and patchy hepatic enhancement on contrast CT/MRI."

• Doppler ultrasound of hepatic veins + IVC — first-line, non-invasive, sensitivity >75% in experienced hands
• Triphasic CT abdomen or MRI liver with hepatic venography — for confirmation and to assess IVC and hepatic vein patency
• Hypercoagulability workup: JAK2 V617F mutation (myeloproliferative neoplasm is the #1 cause of BCS), Factor V Leiden, Protein C/S, Antithrombin III, Antiphospholipid antibody syndrome (APLA — anti-cardiolipin, anti-β2GP1, lupus anticoagulant), PNH (CD55/CD59 by flow cytometry), MTHFR
• CBC with differential for MPN: JAK2 mutation, bone marrow biopsy if MPN suspected

🟡 Priority 3: Leptospirosis — Card Negative, But Not Excluded

Ceftriaxone 2g IV OD for 7 days is the treatment for severe leptospirosis — ensure this dose is being given.

• Leptospira IgM ELISA (more sensitive than card test)
• MAT (Microscopic Agglutination Test) — gold standard, send to reference lab
• Urine PCR for leptospira — leptospires shed in urine from Day 7 onward, now Day 13 → optimal timing

🟡 Priority 4: Enteric Fever with Hepatitis

• Blood cultures × 3 (ideally 10mL each, drawn over 30 minutes)
• Bone marrow culture — remains positive even after 5–7 days of antibiotics; sensitivity ~80–95%

🟡 Priority 5: Visceral Leishmaniasis (Kala-Azar)

• rK39 rapid card test and rK39 ELISA
• Bone marrow aspirate for Leishman-Donovan bodies (if other tests negative)

🟠 Priority 6: Hemophagocytic Lymphohistiocytosis (HLH)

• Prolonged fever not responding to antibiotics
• Cytopenias (his platelets at 1.78L are on the lower side)
• Hepatosplenomegaly
• Rising liver enzymes

• Serum ferritin — if >500: suspicious; >10,000: near-diagnostic
• LDH, triglycerides, fibrinogen
• Bone marrow biopsy for hemophagocytosis
• HScore calculator (if ferritin returns high)

🟠 Priority 7: Other — Brucellosis, TB, EBV/CMV

Consolidated Action Plan

Do Today

Within 48 Hours

Treatment Implications Right Now

Key Takeaway

The caudate lobe hypertrophy on CT is the pivot point of this case. Until hepatic venous outflow obstruction (Budd-Chiari) is excluded with Doppler USG or MRI, it must remain the leading structural diagnosis. Simultaneously, scrub typhus IgM ELISA (not Weil-Felix) is the most important infectious test remaining, and leptospira MAT + urine PCR at Day 13 are at their optimal diagnostic window. A bone marrow study will help across multiple diagnoses simultaneously (typhoid, TB, VL, HLH).

Why KFD Fits This Case Exceptionally Well

Epidemiological Match — Near Perfect

Clinical Features of KFD vs. This Patient

The Biphasic Course — Important Red Flag Here

This patient is on Day 13 — he could be transitioning toward remission or entering the neurological phase. Neurological monitoring is essential right now.

Why Antibiotics Are Not Working — Explained

Diagnosis of KFD

KFDV serology (IgM ELISA) sent to NIV Pune is the definitive next step.

What to Do Now

Immediate

1. Send blood sample to NIV Pune for KFDV IgM/IgG ELISA and RT-PCR — this is the single most important action
2. Ask specifically about tick exposure, forest visits, animal contact, or dead monkey sightings during the Shivamogga visit — history of monkey deaths in the area is a well-known sentinel event for KFD outbreaks
3. Check for vaccination status — a formalin-inactivated KFD vaccine exists and is offered to high-risk populations in endemic areas

Monitoring

1. Daily neurological assessment — look for meningism, altered sensorium, tremors (Phase 2 onset)
2. Serial CBC — watch platelet trend closely for hemorrhagic risk
3. Coagulation profile (PT/INR, aPTT, fibrinogen) — screen for DIC

Treatment

1. Supportive care is the mainstay — no specific antiviral
2. Stop doxycycline (not useful for viral etiology and adds hepatotoxic risk given already elevated LFTs) — unless scrub typhus co-infection not yet excluded
3. Avoid NSAIDs — platelet dysfunction risk in VHF
4. Platelet transfusion threshold: <20,000 or <50,000 with active bleeding

KFD vs. Other Diagnoses — How It Stacks Up Now

Bottom Line

KFD is a very strong diagnosis in this patient. Male, from Goa, travelling to Sagar-Shivamogga (the KFD heartland of India), presenting with prolonged fever, hepatosplenomegaly, GI symptoms, cholestatic hepatitis, rising transaminases, thrombocytopenia, and non-response to antibiotics — this is a textbook KFD presentation until proven otherwise. Send KFDV IgM ELISA and RT-PCR to NIV Pune today. Concurrently assess for the biphasic neurological phase, as this patient is at exactly the right time window for Phase 2 onset.